Ipca Laboratories Ltd. — Share Issue/Capital Change 2020

Sep 2, 2020

THRU ONLINE FILING

September 2, 2020

BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400023 Scrip Code - 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra - (East). Mumbai-400051. Scrip Code: JPCALAB

Dear Sir,

Pursuant to the approval of the shareholders at the Extra Ordinary General Meeting held on 24th October, 2019, in-principle approval received from the Stock Exchanges and pursuant to applications received from the allottees to convert the warran1s allotted to them into equity nd shares, the Board of Directors of the Company at their meeting held on 2 September, 2020 have allotted 5,00,000 Equity shares of RS.2/- each fully paid-up for cash at a price of Rs. 9551- per equity share including a premium of Rs. 953/- per share aggregating to Rs. 47,75,00,0001- to members of the Promoters 1 Promoter Group of the Company.

These equity shares allotted shall rank pari-passu with the existing equity shares of the Company in all respec1s.

The shares allotted now shall be locked-in in accordance with the provisions of Regulations 167 and 168 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

With this allotment, the paid up equity share capital of the Company has increased to 12,68,52,109 equity shares of RS.2/- each aggregating to Rs. 25,37,04,218/-.

The necessary disclosure for this allotment under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed herewith.

Kindly note that the board meeting commenced at 11.00 a.m. and concluded at 11.45 a.m.

Thanking you

Yours faithfully For Ipca Laboratories Limited ~ Harish Kamath Corporate Counsel & Company Secretary

Encl: ala

Ipea Laboratories Ltd. 125 K d" I"I d "I www.ipea.com , an IV I n ustna Estate, CTS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 2262105000 F:+91 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 2266474444 E:ipca@ipca.com CIN: L24239MH 1949PLC007837

DISCLOSURE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS. 2015

==> picture [436 x 591] intentionally omitted <==

----- Start of picture text -----

1. Type of securities issued (viz. equity 5,00,000 Equity Shares of the face value of Rs.
shares, convertibles etc.) 2/- each fully paid-up
2. Type of issuance (further public Preferential Allotment upon conversion of
offering, rights issue, depository warrants allotted
receipts (ADR/GDR), qualified
institutions placement, preferential
allotment etc.
3. Total number of securities issued or 5,00,000 equity shares of Rs. 2/- each fully
the total amount for which the paid-up @ Rs. 955/- per equity share upon
securities will be issued conversion of convertible warrants issued on
7'h November, 2019 and aggregating to Rs.
47,75,00,0001-
4. Names of the investors I allottees Name of the Allottee (All Number of
the allottees are part of Equity Shares
the Company's Promoter I allotted
Promoter Group)
Mr. Premchand Godha 2,26,000
Mr. Pranay Godha 25,000
Mr. Prashant Godha 25,000
Mis. Kaygee Investments 1,20,000
Private limited
Mis. Kaygee Laboratories 64,000
Private limited
MIs. Paschim Chemicals 40,000
Private limited
Total 5,00,000
5. Post allotment of securities- The equity shares of Rs. 2/- each fully paid-up
Outcome of the Subscription, are allotted upon conversion of warrants at a
Issue Price I Allotted Price price of Rs. 955/- per share including a
premium of Rs. 953/- per share
Number of investors I allottees 6 (Six). All the allottees are part of the
Company's Promoters I Promoter Group
6. in case of convertibles - intimation 5,00,000 convertible warrants were issued to
on conversion of securities or on the allottees at the meeting of the Board of
lapse of the tenure of the instrument Directors of the Compnay held on 7 [th]
November, 2019. Each warrant issued were
convertible into 1 equity share of Rs. 2/- each
fully paid up of the Compnay at a price of Rs.
955/- per share including a premium of Rs.
953/- per share, within a period of 18 months
from the date of allotment of warrants. The said
warrants are now converted into equity shares
by the allottees pursuant to this allotment.
----- End of picture text -----

Ipea Laboratories Ltd. www.ipea.eom

125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 2262105000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH 1949PLC007837